Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Therapy for Protein Turnover in Pre-Diabetic CF
NCT02496780Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- Aug 2015
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin, insulin detemir in cystic fibrosis (CF), sponsored by University of Minnesota. Started Aug 2015; status: terminated.
02
Drugs
human insulininsulin detemir
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02496780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496780.